This study evaluated associations of various anthropometric measures of adiposity with a panel of inflammatory and oxidative stress markers in a relatively lean population of Chinese women. METHODS: This analysis included 1,005 Chinese women aged 40-70 years. Plasma concentrations of inflammatory and oxidative stress markers were measured. Anthropometric measurements were taken by trained interviewers. RESULTS: Body mass index (BMI), waist circumference (WC), and waist-to-height ratio (WHtR) were all positively and linearly associated with the inflammatory markers, CRP, TNF-α, soluble TNF-receptor 1 (sTNF-R1), and IL-6. A significant positive association of these measures of adiposity with the oxidative stress marker F2-IsoP-M, a metabolite of F2-IsoPs, but with not F2-IsoPs was found. Differences in biomarkers between extreme quartiles of anthropometric measurements varied widely, ranging from 9.7% for sTNF-R1 to 162.0% for CRP. For each specific biomarker, various anthropometric measurements exhibited similar ability to explain variations in the biomarker, with the biggest partial r 2 (11%) observed for CRP. CONCLUSIONS: This study suggests that both general adiposity (measured by BMI) and central adiposity (measured by WC and WHtR) are positively and similarly associated with various markers of inflammation and oxidative stress in relatively lean Chinese women. The metabolite F2-IsoP-M of F2-IsoPs may be a better marker of in vivo oxidative stress than its parent compounds.
Introduction
Obesity is now viewed as a low-grade inflammatory condition [1] . To date, investigations of obesity and inflammation [2] [3] [4] [5] [6] [7] and oxidative stress [8, 9] have been conducted mainly in Western populations where overweight and obesity are highly prevalent. The relationship between general or central adiposity and inflammation and oxidative stress in a relatively lean population is not well characterized. Data on the effect of fat distribution on inflammation and oxidative stress are mixed [10] [11] [12] [13] , showing stronger associations with measures of central adiposity in some [10, 11] , but not all studies [12, 13] . In addition, many in-flammatory mediators have been found to be involved in obesity-related diseases. Most previous studies of obesity and inflammation have focused mainly on Creactive protein (CRP) [3, 5, 6] . It remains controversial which anthropometric measurements and inflammatory biomarkers are the most appropriate to describe the association of obesity and inflammation or oxidative stress.
The measurement of urinary F 2 -isoprostanes (F 2 -IsoPs) is now well accepted as the most accurate and reliable biomarker of oxidative stress in vivo [14, 15] . Urine is considered an ideal biological material for the measurement of F 2 -IsoPs because, unlike plasma, urine does not have a high lipid content; therefore, there is less concern about artifactual generation of isoprostanes by lipid autoxidation during sampling and storage [16] . After β-oxdidation, 15-F 2t -Isoprostane (15-F 2t -Isop), one of the major F 2 -IsoPs, is converted to 2,3-dinor-5,6-dihydro-15-F 2t -IsoP (F 2 -IsoP-M), which is not subject to renal production [17] . Our previous observations suggest that F 2 -IsoP-M may be a better marker of in vivo systemic oxidative stress than its parent compounds [18] .
The present study evaluated associations of anthropometric measures of adiposity with a panel of inflammatory and oxidative stress markers and examined potential heterogeneity by measures of fat distribution among 1,005 middle-aged women in Shanghai, China, with a mean BMI of 24.6 kg/m 2 .
Methods and procedures

Study participants
This cross-sectional analysis was conducted among 1,005 women originally selected for a nested casecontrol study of colorectal cancer among participants of the Shanghai Women's Health Study (SWHS), an ongoing, population-based, prospective cohort study. The design and methods of the SWHS have been described in depth elsewhere [19, 20] . Briefly, at the baseline survey conducted between 1997 and 2000, 74,941 women aged 40-70 y from 7 typical urban communities of Shanghai were recruited (participation rate: 92.7%). All women completed a detailed baseline survey that collected information on demographic characteristics, lifestyle and dietary habits, medical history, and other exposures. A detailed assessment of physical activity was obtained using a validated questionnaire [21] . The study was approved by the relevant institutional review boards for human research in both China and the United States. Written informed consent was obtained from all study participants.
Anthropometry
Participants were asked to wear light indoor clothing when they were measured for weight, height, and circumferences of the waist and hips by trained interviewers. The measurement was conducted uniformly according to a standard protocol. Waist circumference (WC) was measured at 2.5 cm above the umbilicus and hip circumference (HC) at the level of maximum width of the buttocks with the participant in a standing position. Circumferences and heights were measured to the nearest 0.1 cm. Weight was measured to the nearest 0.1 kg using a digital weight scale that was calibrated every 6 months. All measurements were taken twice. A tolerance limit of 1 kg was set for the weight measurement and 1 cm for height and circumference measurements. A third measurement was taken if the difference between the first 2 measurements was greater than the tolerance limit. Using the average of the 2 closest measurements, waist-to-hip ratio (WHR; waist circumference divided by hip circumference), BMI (weight in kilograms divided by the square of height in meters), and waist-to-height ratio (WHtR; waist circumference divided by height in centimeters) were then calculated for the analysis.
Dietary intake
Habitual dietary intake data over the 12 months preceding the interview were collected during in-person interviews using a validated food-frequency questionnaire (FFQ) that included 77 food items/groups commonly consumed in Shanghai [19] to assess intake of dietary antioxidant-rich foods (such as fruits and vegetables) and antioxidant vitamins (such as vitamins C and E). Nutrient consumption and total energy intake were calculated by summing the product of food intake and the nutrient content of the food item based on the 2002 Chinese Food Composition Tables [22] .
Biomarker measurement
At study enrollment, 76% of cohort members donated baseline blood and urine samples; an additional 12% of cohort members donated a urine sample during the first follow-up survey (approximately 2 years later) [19, 20] . After collection, samples were kept at 0-4
• C and processed within 6 hours. Immediately after processing, all samples were stored at −70
• C until laboratory analyses were conducted.
Cytokines and their receptors were measured by using Millipore's MILLIPLEX R MAP High Sensitivity Human Cytokine multiplex kit for IL-1β, IL-6, and TNF-α and the MILLIPLEX R MAP Human Soluble Cytokine Receptor Panel multiplex kits for soluble IL-6 receptor (sIL-6R), soluble GP130 (sGP130, a regulator of IL-6/sIL-6R complex signaling), soluble TNF-R1 (sTNF-R1), and sTNF-R2. Assays were conducted in duplicate at the Hormone Assay and Analytical Services Core at Vanderbilt University, Nashville, USA, from 2009 to 2010, following relevant manufacturer's instructions. High-sensitivity CRP measurements were performed at Vanderbilt University Hospital's lipids lab using the ACE R High Sensitivity CReactive Protein Reagent (ACI-22) for the first batch and the CRP (HS) Wide Range kit (Pointe Scientific, Canton, MI) for the second batch. Thus, we adjusted for batch in all analyses. The limits of detection were as follows: TNF-α, 0.05 pg/mL; sTNF-R1, 9.6 pg/mL; sTNF-R2, 16.9 pg/mL; IL-1β, 0.06 pg/mL; IL-6, 0.10 pg/mL; sGP130, 7.2 pg/mL; sIL-6R, 3.6 pg/mL; and CRP, 0.1 mg/L. Intra-assay coefficients of variation were 11.8% for TNF-α, 7.5% for sTNF-R1, 5.5% for sTNF-R2, 17.4% for IL-1β, 15.5% for IL-6, 3.6% for sGP130, and 3.8% for sIL-6R in this study; interassay coefficients of variation were < 21% in our validation study conducted at the same core lab [23] .
Urinary excretion of F 2 -IsoPs and their major metabolite, F 2 -IsoP-M, were measured by gas chromatography/negative ion chemical ionization mass spectrometry (GC/NICI MS) at the Vanderbilt Eicosanoid Core Laboratory. Details of this method have been reported elsewhere [17] . Both F 2 -IsoPs and F 2 -IsopM concentrations were expressed as ng/mg creatinine. The lower limit of sensitivity was approximately 5 pg. The precision of the assay was ± 6% and accuracy was 96% [17] .
Statistical analysis
Participants with less than the detectable limits of inflammatory and oxidative stress markers were excluded from the analysis (TNF-α, n = 4; sTNF-R1, n = 5; sTNF-R2, n = 1; IL-1β, n = 102; IL-6, n = 71; sGP130, n = 1; sIL-6R, n = 3; CRP, n = 90; F 2 -IsoPs, n = 0; and F 2 -IsopM, n = 0), as were participants with outliers according to a box plot (sTNF-R1, n = 1; sTNF-R2, n = 3; sGP130, n = 1; sIL-6R, n = 6; F 2 -IsoPs, n = 2; and F 2 -IsopM , n = 2).
Log-transformation was conducted to normalize the distribution of the inflammatory markers studied. Geometric means of these markers were obtained based on the least square means estimated using a general linear regression model according to quartiles of anthropometric measurements after adjustment for potential confounding factors. Covariates adjusted for included age; education; occupation; total physical activity; Charlson comorbidity index [24] ; history of other infectious or inflammation-related diseases that are not included in the Charlson comorbidity index; menopausal status; cigarette smoking; alcohol consumption; regular use of aspirin or other non-steroidal anti-inflammatory drugs (NSAIDs); regular use of vitamin supplements; dietary intakes of total calories, total fruits, and total vegetables; and assay batch. Use of antibiotics and vitamin supplements in the week before sample collection was also adjusted for in the model. The association of anthropometric measures of obesity with biomarkers was examined with and without adjusting for physical activity. Mutual adjustment for BMI and WHR was performed to evaluate independent effects of these two measures of adiposity on biomarkers.
Tests for linear trend were performed by entering categorical variables as continuous variables in the linear regression models. We also used a restricted cubic spline linear regression model to graphically illustrate the shape of the correlations between anthropometric measures of adiposity and biomarkers. Knots were placed at the 5 th , 50 th , and 95 th percentiles of the distribution of these measurements. We excluded participants with measures of adiposity below the 0.5 th and above the 99.5 th percentiles from the spline model to minimize the influence of outliers.
In sensitivity analyses, to reduce the influence of potential acute inflammation on our results, participants with CRP > 10 mg/L were excluded, and, to check whether non-detection differed by measures of adiposity, participants with less than the detectable limits of markers were included by assigning them a value of one-half the detectable limit for each marker with an undetectable measurement. In addition, we evaluated the association between BMI and inflammatory markers among non-obese women (BMI < 30 kg/m 2 ) and conducted stratified analyses by chronic infectious or inflammatory disease status. Multicollinearity was not a concern, since the variance inflation factors for all variables were < 3 (the variance inflation factors were about 1 for most covariates). All statistical tests were two-sided and were performed using SAS statistical software, version 9.1 (SAS Institute, Cary, NC). 
Results
Characteristics of study participants
The mean age ± SD of study participants was 58.5 ± 8.8 years. Mean BMI was 24.6 ± 3.5 kg/m 2 and obesity prevalence (BMI 30) was 6.7%. Study participants' characteristics according to quartiles of BMI and WC are presented in Table 1 . Women with higher BMI and WC were likely to be older and to have lower educational attainment, but higher total energy intake. They were also likely to have a history of infectious or inflammation-related diseases and a higher Charlson comorbidity index. However, the distribution of other inflammation-related factors, such as physical activity, cigarette smoking, or intake of fruits and vegetables, did not depend upon quartile of BMI or WC. All anthropometric measures of adiposity studied (BMI, WHtR, WC, WHR, and HC) were significantly and strongly correlated with each other (r ranged from 0.70 to 0.96), with the exception of WHR, which was moderately correlated with BMI (r = 0.44) and weakly correlated with HC (r = 0.20) (Supplemental Table 1 ). Apart from age and menopausal status, the characteristics of this subset of the cohort were not significantly different from the rest of the cohort (data not shown).
Correlation between anthropometric measures of adiposity and biomarkers studied
We used a restricted cubic spline linear regression model to graphically illustrate the shape of the corre-P for overall significance of curve < 0.0001 P for linear relation < 0.0001 P for nolinear relation = 0.22 P for overall significance of curve < 0.0001 P for linear relation = 0.03 P for nolinear relation = 0.90 P for overall significance of curve = 0.0001 P for linear relation = 0.36 P for nolinear relation = 0.39 P for overall significance of curve = 0.64 P for linear relation = 0.54 P for nolinear relation = 0.80 P for overall significance of curve = 0.004 P for linear relation = 0. lations between anthropometric measures of adiposity and biomarkers after adjustment for age, lifestyle factors, and related health conditions. The concentrations of CRP and TNF-α were linearly and positively associated with BMI (Fig. 1, panels A and B) , with a P for overall significance of < 0.0001 for both markers. IL-6 was also positively associated with BMI, although tests for linearity were not statistically significant (Fig. 1,  panel C) . A similar positive linear association was found for WC with each of these markers (Fig. 2 , panels A, B, and C), with a P for overall significance of 0.0001 for all three markers. Urinary concentrations of the oxidative stress marker F 2 -IsoPs were not significantly correlated with either BMI (Fig. 1, panel D) or WC (Fig. 2, panel D) . However, significant positive associations were found between the major metabolite of F 2 -IsoPs (F 2 -IsoP-M) and BMI (Fig. 1, panel E) and WC (Fig. 2, panel E) . 
Multivariable-adjusted concentrations of biomarkers by categories of anthropometric measures of adiposity
Multivariable adjusted concentrations of CRP, TNF-α, sTNF-R1, IL-1β, IL-6, and F 2 -IsoP-M increased with increasing quartiles of BMI ( Table 2 ). The difference in adjusted geometric means of various biomarkers between the highest and lowest quartiles of BMI varied widely, ranging from 9.7% for sTNF-R1 to 118.0% for CRP. Similar significant positive associations with WC (Table 2) and WHtR (Supplemental Table 2) were found for CRP, TNF-α, sTNF-R1, sTNF-R2, IL-6, and F 2 -IsoP-M. WHR was correlated with 32 .00 d a Adjusted for age, education, occupation, cigarette smoking, alcohol consumption, physical activity, menopausal status, regular use of vitamin supplements, regular use of aspirin or other non-steroidal anti-inflammatory drugs, total fruit and vegetable intake, total energy intake, comobidity index, other infectious or inflammation-related diseases, use of antibiotics or vitamin supplements in the week before sample collection, and assay batch using general linear models. b Quartile cutoffs for body mass index: 22.3, 24.4, and 26.7 kg/m 2 ; quartile cutoffs for waist circumference: 73, 80, and 87 cm. c Difference (%) = (geometric mean of the inflammatory marker for each quartile -geometric mean for the lowest quartile)/geometric mean for the lowest quartile of body mass index or waist circumference. d p < 0.01. e p < 0.05. CRP: C-reactive protein; F 2 -IsoPs: 15-F 2t -isoprostanes; F 2 -IsoP-M: 2,3-dinor-5,6-dihydro-15-F 2t -isoprostanes; IL-1β: interleukin 1β; IL-6: interleukin 6; sGP130: soluble GP130; sIL-6R: soluble IL-6 receptor; sTNF-R1: soluble tumor necrosis factor receptor 1; sTNF-R2: soluble tumor necrosis factor receptor 2; TNF-α: tumor necrosis factor α. age, education, occupation, cigarette smoking, alcohol consumption, physical activity, menopausal status, regular use of vitamin supplements, regular use of aspirin or other non-steroidal anti-inflammatory drugs, total fruit and vegetable intake, total energy intake, Charlson comobidity index, other infectious or inflammation-related diseases, use of antibiotics or vitamin supplements in the week before sample collection, and assay batch. CRP: C-reactive protein; F 2 -IsoPs: 15-F 2t -isoprostanes; F 2 -IsoP-M: 2,3-dinor-5,6-dihydro-15-F 2t -isoprostanes; IL-1β: interleukin 1β; IL-6: interleukin 6; MET: metabolic equivalent; sGP130: soluble GP130; sIL-6R: soluble IL-6 receptor; sTNF-R1: soluble tumor necrosis factor receptor 1; sTNF-R2: soluble tumor necrosis factor receptor 2; TNF-α: tumor necrosis factor α; WC: waist circumference; WHR: waist-to-hip ratio; WHtR: waist-to-height ratio.
some but not all of these markers (Supplemental Table 2), and the strength of the correlations for WHR was somewhat weaker than the correlations for BMI, WHtR, and WC. Analyses of these anthropometric measures of adiposity with and without further adjustment for physical activity yielded almost identical results.
Correlation between soluble receptors and their ligands
sTNF-R1 and sTNF-R2 were modestly correlated with TNF-α (Spearman r = 0.23 and 0.30, respectively). Correlations between soluble TNF receptors and anthropometric measures of adiposity were weaker than those for TNF-α (Table 2 ). IL-6 and its receptors (sIL-6R and sGP130) were not significantly correlated with each other (Spearman r = −0.04 and 0.04, respectively). BMI and WC were correlated with IL-6 but not with its soluble receptors ( Table 2) . We also evaluated the ratios of TNF-α and IL-6 to their soluble receptors in relation to anthropometric measures of adiposity. No significant correlations were found (data not shown).
Explanatory ability of anthropometric measures of adiposity
Partial r 2 was used to assess the contribution of anthropometric measures of adiposity to variations in inflammatory/oxidative stress markers when other explanatory variables were held constant. For each specific biomarker, different anthropometric measures of adiposity showed similar explanatory ability (partial r 2 ) in the fully adjusted model, although the partial r 2 of WHtR and WC for CRP and of WHtR for F 2 -IsoP-M were slightly greater than other anthropometric measures of adiposity (Table 3) . Of the biomarkers studied, the biggest partial r 2 was found for CRP; approximately 11% of variation in CRP can be explained by either WC or WHtR, after accounting for other explanatory variables. Similarly, the standardized beta coefficients associated with various anthropometric measures of adiposity for each specific biomarker were comparable, although the coefficient associated with WHR was, in general, smaller than other measures of adiposity studied.
Effect of fat distribution and sensitivity analyses
Mutual adjustment for BMI and WC was not conducted, because of concerns about the high collinearity between these two variables (r = 0.83) (Supplemental Table 1 ). Mutual adjustment for BMI and WHR (r = 0.44) was conducted, which resulted in slight changes in the associations of BMI with the biomarkers studied (Supplemental Table 3 ). However, additional adjustment for BMI substantially attenuated the association of WHR and TNF-α.
Exclusion of participants with CRP > 10 mg/L (n = 29, 2.89%) did not markedly change the results, nor did inclusion of participants with less than the detectable limits of markers (data not shown). We also conducted analyses restricted to non-obese women (BMI < 30 kg/m 2 ; n = 938, 93.3%). Results were similar to those observed for the entire study population, although correlations between BMI and some of the biomarkers studied became slightly weaker (data not shown). We further evaluated whether the association between anthropometric measures of adiposity and inflammation or oxidative stress differed by prevalent health conditions, including history of tuberculosis, chronic bronchitis, asthma, chronic gastritis, chronic hepatitis, ulcerative colitis, diabetes, hypertension, or coronary heart disease. No significant effect modification by the status of these health conditions was suggested (all P for interaction > 0.05).
Discussion
In this relatively lean population of 1,005 Chinese women, measures of overall adiposity (such as BMI) and central adiposity (such as WC) were found to be positively correlated with circulating inflammatory (CRP, TNF-α, sTNF-R1, sTNF-R2, IL-1β, and IL-6) and urinary oxidative stress markers (F 2 -IsoP-M). These associations were independent of age, socioeconomic status, and other inflammation-related factors, such as lifestyle and dietary factors, inflammationrelated health conditions, and medication use.
Many epidemiological studies and preclinical observations have demonstrated a relationship between obesity and low-grade chronic inflammation [2] [3] [4] 6, 7] . Most previous studies have largely involved populations with a high prevalence of obesity (29%-46%) [4, 6, 7] . Our study provides support for and extends previous findings by showing a continuous, linear, and positive relation between inflammatory and oxidative stress markers and anthropometric measures of adiposity in a relatively lean population with a prevalence of obesity of 6.7%. This finding is also supported by the observation that many obesity-related diseases, such as cardiovascular disease, are seen in individuals with "normal/healthy" body weight [2, 10, 25] . Our data further underscore the importance of weight control in the prevention of many obesity-related diseases.
IL-6, IL-1β, and TNF-α are three pivotal proinflammatory cytokines that have been found to be involved in many obesity-related diseases [26, 27] . CRP, a sensitive marker of low-grade systemic inflammation, is produced in the liver through the stimulation of pro-inflammatory cytokines, including mainly IL-6, IL-1β, and TNF-α [28] . As a downstream biomarker, CRP provides functional integration of overall upstream cytokine activation [29] . Most previous studies of obesity and inflammation have focused mainly on CRP [3, 5, 6] . In this study, we comprehensively evaluated a panel of inflammatory markers and soluble receptors of cytokines. Overall, values for partial r 2 , which reflects the proportion of variation in biomarker levels that can be explained by anthropometric measures of adiposity when other explanatory variables are held constant, were small, ranging from 1% for sTNFRs to 11% for CRP. The biggest partial r 2 was observed for CRP, suggesting that CRP may be the most appropriate marker (with respect to strength of the correlation) for describing the obesity and inflammation association.
BMI, a measure of general adiposity, has been used as the primary measure of body fatness in most previous studies [2, [4] [5] [6] . However, this measure is unable to distinguish fat mass and non-fat mass, particularly among elderly people. On the other hand, WC, WHtR, and WHR, measures of central adiposity, are less affected by loss of muscle mass during aging and represent a measure of adiposity that takes into account the accumulation of abdominal fat [30] [31] [32] . Among middle-aged and elderly adults, accumulation of visceral fat has been strongly associated with inflammation in some studies [2, [10] [11] [12] [13] , particularly in women [33] [34] [35] . However, no heterogeneity in the association with visceral versus subcutaneous adipose tissue volume, as assessed by computerized tomography, was observed in the Framingham Heart Study [13] . Measures of both general and central adiposity have been positively and similarly associated with inflammation and oxidative stress [13] . Similar results were also found in our study. Various measures of adiposity exhibit similar explanatory ability (partial r 2 ) for variations of each specific biomarker. sTNF-R2 is considered to better reflect long-term average circulating concentrations of TNF-α and has been used as an indicator of TNF-α activity in epidemiological studies [36, 37] . However, few studies have comprehensively evaluated the relation of soluble receptors of cytokines with their ligands and with other inflammatory determinants to help understand the biological correlates of these soluble receptors [38, 39] . In this study, we found that the correlations between soluble receptors (sTNF-R1, sTNF-R2, sIL-6R, and sGP130) and their ligands (TNF-α and IL-6) were weak. Anthropometric measures of adiposity were related to IL-6 and TNF-α, but were not or were only weakly related to their soluble receptors. Therefore, using soluble receptor levels to represent TNF-α or IL-6 levels is not supported by this study. In fact, recognition of the biological action of soluble receptors has led to their therapeutic use as cytokine inhibitors in preclinical studies [40] .
In a multi-investigator study sponsored by the National Institute of Environmental Health Sciences (NI-EHS), termed the Biomarkers of Oxidative Stress (BOSS) Study, quantification of F 2 -IsoPs by mass spectrometry was found to be the most accurate method to assess endogenous oxidative stress [17] . Positive relationships between F 2 -IsoPs and the anthropometric measurements BMI and WHR have been found in some [8, 9] but not all previous studies [18] . One possible reason for this inconsistency, besides study design and subject characteristics, is the method used to quantify F 2 -IsoPs. In previous studies, immunoassays for F 2 -IsoPs were frequently used, in which a cross-reactivity exists between antibodies for F 2 -IsoPs and structurally similar isomers [18] , such as F 2 -IsoP metabolites [41] . In addition, unlike F 2 -IsoPs, F 2 -IsoP metabolite in urine is not subject to autoxidation or renal production [17] . We measured urinary F 2 -IsoPs and their major metabolite, F 2 -IsoP-M, by a mass spectrometry-based method. Our finding of a significant positive association of anthropometric measures of adiposity with F 2 -IsoP-M but not F 2 -IsoPs suggests that F 2 -IsoP-M may be a better marker of in vivo oxidative stress than its parent compounds. This finding is also supported by another parallel study conducted in the SWHS that recently and independently evaluated the obesity and oxidative stress association [42] . In addition, increased risk of breast cancer was found to be more closely related to urinary F 2 -IsoP-M than F 2 -IsoPs in the SWHS [18] . Clearly, this hypothesis needs to be further investigated.
Several methodological limitations of this study should be considered. The study was cross-sectional in design; thus, no causal relationships can be inferred. Individuals in different categories of obesity are also likely to differ in several other respects. For example, health conditions, particularly some inflammationrelated diseases, may result in changes in anthropometric measures of adiposity, thus potentially biasing the obesity and inflammation association. However, our study found no significant heterogeneity in the association for groups with versus without a history of chronic infectious or inflammatory diseases. In addition, although detailed information on a wide range of factors related to inflammation and oxidative stress was available, allowing us to control for potential confounding by these factors, we could not completely rule out the possibility of residual confounding due to unmeasured or inadequately measured covariates.
In conclusion, this study suggests that measures of both general (measured by BMI) and central adiposity (measured by WC and WHtR) were positively associated with inflammation and oxidative stress in women. F 2 -IsoP-M may be a better marker of in vivo oxidative stress than its parent compounds F 2 -IsoPs. Because the proportion of variation in inflammation and oxidative stress that can be explained by anthropometric measures of adiposity was small, further investigations are clearly needed to identify modifiable and genetic factors related to chronic inflammation and oxidative stress in humans.
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